Rheumatology Leaders Join a Coalition of National Medical Specialties in Urging Congress to Protect Patients from Prior Authorization Requirements in Medicare Advantage Plans
Dr. John Cush RheumNow
7 years 4 months ago
QD Clinic - daily lessons and cases from the Rheumatology clinic.
RA patient, not quite controlled, needs to optimized MTX therapy
Features Dr. Jack Cush https://t.co/ZoX2biwv7M
Dr. Jack Cush reviews the news and journal articles of note from this past week on RheumNow.com.
Dr. John Cush RheumNow
7 years 4 months ago
FDA sent an "untitled"letter to "R3 Stem Cell" for touting birth tissue products as Rx for ailments (without scientific evidence). FDA also won a case against "US Stem Cell clinics" for adulterated & misbranded stem cell products https://t.co/bQpRHxR9G8 https://t.co/oLBPKZ1lxX
k dao KDAO2011
7 years 4 months ago
Word of the day:
Ischuria= urinary retention.
My patient with systemic sclerosis and severe spinal stenosis developed ischuria and now has to self-cath.
#rheumnow
Reuters has reported that Mallinckrodt Plc has tentatively agreed to pay $15.4 million to resolve a US Justice Department investigation into company promotional practices for Acthar gel.
Dr. John Cush RheumNow
7 years 4 months ago
Transparency is coming? The Prices will soon be Included in TV Drug Ads. HHS Secretary Alex Azar has finalized regulations requiring drug companies to disclose list prices of medications costing more than $35 for a month’s supply. https://t.co/P2DPwXGYXK
Analysis of Rheumatoid Arthritis patients enrolled and treated as part of the British Society for Rheumatology Biologics Registry shows that sustained remission or low disease activity state (LDA) on TNF inhibitor treatment is uncommon and that combing methotrexate with an anti-TNF increases the odds of sustained remission/LDA.
Dr. John Cush RheumNow
7 years 4 months ago
The overall prevalence of gout among US adults is 3.9%, affecting 9.2 million people. Hyperuricaemia prevalence is 14.6% - affecting 32.5 million in the US. Data from NHANES NHANES 2015–16 https://t.co/3g05GmUDUA
Dr. John Cush RheumNow
7 years 4 months ago
Korean Natl Claims Database examined RA & risk of opportunistic infx- OI, H zoster & candidiasis are seen in early RA. SIR for OI in early RA=1.14 (95% CI, 1.05‐1.23). H zoster (1.12), candidiasis (2.40); Age, steroids & comorbidity increased OI risk https://t.co/U7LPMpmPqG
The US Food and Drug Administration convened a public hearing and specialty panel on May 31st to review the potential use, safety and effectiveness of cannabidiol (CBD) products that do not contain THC.In his opening remarks, the FDA acting Commissioner Dr. Ned Sharpless said, "critical questions remain about the safety" of CBD products, especially since the growth of the CBD market has exploded in the past year.
Dr. John Cush RheumNow
7 years 4 months ago
CDC has updated its recommendations for TB testing of health care personnel. All HCP should be tested initially but after TB risk assessment, there is no need for routine or serial TB testing in the absence of exposure or ongoing risk of TB. https://t.co/qtAdz8d7OK
Dr. John Cush RheumNow
7 years 4 months ago
Metformin, was given to a mouse model Sjogrens (NOD)/ShiLtJ mice) & reduced salivary inflammation, IL-6,TNFα, IL-17 mRNA, improved salivary flow rate, suppressed effector T cells, inducec regulatory T cells & B cell diff. Why are mice so easy, SS so tough? https://t.co/yC5fJIBBEx
